Orgenesis Inc (NASDAQ:ORGS)
| 0.4501 Delayed Data As of Dec 01 |  -0.0115 / -2.49%Today’s Change | 0.38 Today|||52-Week Range 2.64 | -76.92% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $14.4M |
Company Description
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Contact Information
Orgenesis, Inc. 20271 Goldenrod Lane Germantown Maryland 20876 |
Employees
Shareholders
| Individual stakeholders | 4.74% |
| Mutual fund holders | 4.24% |
| Other institutional | 3.50% |
Top Executives
| Vered Caplan | Chairman, President & Chief Executive Officer |
| Elliot Maltz | Chief Financial Officer |
| Sarah Ferber | Chief Scientific Officer |
| Heiko von der Leyen | Medical Director |
| Gerhard Bauer | Vice President -Global Product Implementation |
